RecruitingNot ApplicableNCT05663931

Diabetes Toolkit at Discharge

Implementation and Testing of a Diabetes Discharge Intervention to Improve Safety During Transitions of Care


Sponsor

Northwestern University

Enrollment

120 participants

Start Date

Jan 10, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this randomized clinical trial is to implement the DM Discharge Toolkit into hospital discharge and assess the effect of the DM Discharge Toolkit on patients newly requiring insulin.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria4

  • English speaking patients
  • years of age and older
  • Expected survival \>90 days
  • Need for new insulin at time of hospital discharge

Exclusion Criteria4

  • Patients with the inability to give informed consent
  • Non-English speaking
  • Not diagnosed with diabetes
  • Not been newly prescribed insulin

Interventions

OTHERDM Discharge Toolkit

The DM Discharge Toolkit is a multi-modal intervention consisting of a 3-D printed DM survival "kit" that stores DM self-care supplies (e.g., glucose meter) and technical skills (e.g., injection) simulation materials (e.g. simulation skin), whose use is integrated with a website (https://mydiabeteskit.com) containing standardized DM "Survival" education content.


Locations(1)

Northwestern Memorial Hospital

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05663931


Related Trials